• Mashup Score: 46

    The impact of sex on the baseline characteristics, morphology, and clinical presentation of degenerative aortic stenosis (AS) is well-documented but remains poorly understood. Unlike valve surgery, for which patients have been predominantly male, percutaneous treatment of AS has shown balanced representation of both sexes, with women demonstrating greater benefit from transfemoral aortic valve replacement compared to surgical treatment. This review explores sex-specific differences in the epidemiology, pathophysiology, diagnostic challenges, treatment approaches, and clinical outcomes of degenerative AS.

    Tweet Tweets with this article
    • Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women - Structural Heart https://t.co/91nisBFdyP @giuliamasiero3 @valeriaparadies @mirvatalasnag @ChiaraFraccaro @BelliniBarbara @BottiGiulia @belcid7 @Marta33717088 @MartineGilard @JGrapsa @JuMehilli &

  • Mashup Score: 6

    Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged

    Tweet Tweets with this article
    • 🌟 Now Live: Special Issue on Women in Structural Heart Disease We’re proud to share this edition highlighting the women leading innovation, research, & collaboration. Curated by guest editor Dr. Anita Asgar, it’s a powerful look at excellence in action! https://t.co/xyzlrzMX8u https://t.co/B4fvA7H7ok

  • Mashup Score: 4

    In recent years, various interventional therapies, e.g., edge-to-edge therapies, percutaneous annuloplasty, or orthotopic valve implantation, have emerged to treat symptomatic, inoperable patients with tricuspid regurgitation (TR), as recommended by the current European Society of Cardiology guideline.1 The occurrence of TR increases with age, reaching a prevalence of 4% in patients older than 75 years.2 To plan interventional therapy for these patients—such as percutaneous annuloplasty or orthotopic valve implantation—computed tomography (CT) is routinely used to characterize tricuspid valve anatomy and right heart morphology.

    Tweet Tweets with this article
    • New insights from a small study using AI-powered CT analysis for tricuspid valve interventions found: ✅ Deep learning enables fast, accurate right heart assessment ✅Results are consistent regardless of user experience https://t.co/XtLX0Iqnkn #CardioEd #CardioResearch https://t.co/tWhEmMrHqK

  • Mashup Score: 10

    Coronary cannulation (CC) after transcatheter aortic valve replacement (TAVR) is crucial as the indication expands to younger patients.1 The Evolut FX valve (Medtronic Inc, Minneapolis, Minnesota) allows fluoroscopic assessment of commissure alignment by the golden markers positioned at its inflow and commissural alignment has been associated with improvement in coronary access following valve implantation.2,3,4 The newer Evolut FX+ (Medtronic Inc, Minneapolis, Minnesota) has 3 apertures positioned 120 degrees apart designed to facilitate CC.

    Tweet Tweets with this article
    • 🆕 Findings from CANNULATE TAVR II: Faster right coronary cannulation with the Evolut FX+ vs. previous-gen Despite ~50% of coronaries not aligning with valve apertures, 100% success rate using standard technique https://t.co/XBjOKsuB6F #CardioEd #CardioResearch https://t.co/nw5XMrp8Cb

  • Mashup Score: 13

    Management of aortic stenosis (AS) typically involves surveillance until severe, symptomatic AS develops, at which point aortic valve replacement (AVR) is recommended. However, recent trials suggest that earlier transcatheter AVR or surgical AVR (TAVR or SAVR)—performed before patients reach symptomatic severe AS—may improve outcomes. We conducted a meta-analysis to synthesize data from recent randomized controlled trials (RCTs) comparing early AVR with conservative management.

    Tweet Tweets with this article
    • 🆕 meta-analysis: Early aortic valve replacement before severe symptomatic AS shows no significant benefit for most hard endpoints like mortality or MI but may reduce stroke. https://t.co/6bu2D8BnZJ @TayyabShahMD @AlexandraLansky @PopmaJeffrey https://t.co/4jixciySnA

  • Mashup Score: 46

    The impact of sex on the baseline characteristics, morphology, and clinical presentation of degenerative aortic stenosis (AS) is well-documented but remains poorly understood. Unlike valve surgery, for which patients have been predominantly male, percutaneous treatment of AS has shown balanced representation of both sexes, with women demonstrating greater benefit from transfemoral aortic valve replacement compared to surgical treatment. This review explores sex-specific differences in the epidemiology, pathophysiology, diagnostic challenges, treatment approaches, and clinical outcomes of degenerative AS.

    Tweet Tweets with this article
    • Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women - Structural Heart https://t.co/91nisBFdyP @giuliamasiero3 @valeriaparadies @mirvatalasnag @ChiaraFraccaro @BelliniBarbara @BottiGiulia @belcid7 @Marta33717088 @MartineGilard @JGrapsa @JuMehilli &

  • Mashup Score: 15

    Elsevier journal websites will be undergoing maintenance on Saturday, May 31st from 8am to 12pm US Eastern (4 hours). During this timeframe, we ask that you refrain from logging in or registering to avoid any difficulty with this functionality. We apologize for the inconvenience.

    Tweet Tweets with this article
    • 📢 The May issue of Structural Heart is here! This month’s highlights: 🔹Redo TAVR and Surgical Explants 🔹Conduction Disorders After TAVI 🔹Real-World Outcomes in Severe TR 🔹TAVI in Very Low-Gradient AS 📖 Read the full issue now: https://t.co/kp0xsBC9m7 #CardioResearch https://t.co/LIbKrw3z2v